OKYO
OKYO Pharma Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$1.40
−0.71%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$0.06
- Revenue estimate
- —
Latest reported
- Last report date
- Jun 3, 2026
- EPS actual
- -$0.04
- EPS estimate
- -$0.08
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +8.5%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jun 3, 2026 | -$0.08 | -$0.04 | Beat 49.75% | — |
| Jul 18, 2025 | -$0.05 | -$0.07 | Miss -32.78% | — |
| Jan 29, 2025 | — | -$0.08 | — | — |
| Oct 2, 2024 | — | -$0.10 | — | — |
| Sep 30, 2023 | — | -$0.00 | — | — |
| Sep 30, 2022 | — | -$0.00 | — | — |
| Mar 31, 2022 | — | -$0.47 | — | — |
| Sep 30, 2021 | — | -$0.00 | — | — |
| Sep 30, 2020 | — | -$0.15 | — | — |
| Sep 30, 2019 | — | -$0.16 | — | — |
| Sep 30, 2018 | — | -$0.00 | — | — |
| Mar 31, 2018 | — | -$0.00 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026